ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
124.729,40
-0,73%
S&P 500
5.267,84
-0,74%
US Dollar vs BRL
5,1446
0,00%
Bitcoin
67.656,42
-0,39%
Brent Oil
81,115
-0,24%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. Reino Unido
  5. LSE
  6. BTG (BGC)

  7. BTG (BGC) Notícias

BGC

BTG (BGC)

BTG
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:LSE:BGC
DataHoraFonteTítuloCódigoCompanhia
21/01/201919:00PR Newswire (US)Australian Patient Treated With DC Bead LUMI™, the First Commercially Available Radiopaque Drug-Eluting BeadLSE:BGCBTG
08/01/201912:00PR Newswire (US)BTG and OMNY Partner to Improve Treatment of Snake Bite VictimsLSE:BGCBTG
21/12/201812:00PR Newswire (US)BTG Announces National Reimbursement for TheraSphere® in FranceLSE:BGCBTG
20/09/201803:00PR Newswire (US)BTG Announces Global Launch of the ICEfx™ Cryoablation SystemLSE:BGCBTG
15/06/201803:00RNS Non-RegulatoryBTG PLC Result of FDA Advisory Committee vote on ElevairLSE:BGCBTG
11/06/201803:00PR Newswire (US)ELEVATE Study Aims to Improve Selection Criteria and Outcomes for Patients with Severe Emphysema Treated with the PneumRx™ ...LSE:BGCBTG
12/12/201710:00PR Newswire (US)BTG plc: Northwestern University Adopts Y90 TARE with TheraSphere® as First-Line Treatment for HCCLSE:BGCBTG
16/11/201710:00PR Newswire (US)New Consensus Guidelines Provide Specific Recommendations for Use of Voraxaze® in Patients with Delayed Methotrexate Clearan...LSE:BGCBTG
09/10/201703:00PR Newswire (US)First Patient Treated With Microscopic Beads Pre-loaded With a Targeted Cancer Drug and Visible on CT ScansLSE:BGCBTG
13/09/201708:00PR Newswire (US)Vistogard® and Voraxaze® Added to Revised Guidelines for Stocking of Antidotes in US HospitalsLSE:BGCBTG
21/08/201708:00PR Newswire (US)BTG and SIO Expand Immuno-Oncology / Interventional Oncology Grant ProgrammeLSE:BGCBTG
13/06/201708:05PR Newswire (US)New Study Shows Patients Treated With CroFab® Have Improved Recovery From Copperhead EnvenomationLSE:BGCBTG
10/06/201709:30PR Newswire (US)New Study Shows IO Loop™ Improves Patient Follow-up, Engagement and Satisfaction Following Treatment With TheraSphere®LSE:BGCBTG
07/06/201708:00PR Newswire (US)SIO Announces First Grants in Interventional Oncology / Immuno-Oncology Research ProgrammeLSE:BGCBTG
19/05/201708:00PR Newswire (US)BTG and HealthLoop Collaborate on IO Loop™, an Exclusive Service to Connect Patients and Interventional Oncologists Through...LSE:BGCBTG
20/04/201703:00PR Newswire (US)First European Patients Treated With DC Bead LUMI™ Radiopaque Drug-Eluting BeadsLSE:BGCBTG
07/03/201704:00PR Newswire (US)BTG Announces CE Mark Certification for DC Bead LUMI™, the First Commercially Available Radiopaque Drug-Eluting Bead in the...LSE:BGCBTG
15/02/201711:00PR Newswire (US)BTG and Society of Interventional Oncology to Explore Role of Minimally Invasive Therapies in Immuno-oncologyLSE:BGCBTG
05/12/201605:47RNS Non-RegulatoryBTG PLC PneumRx GOLDLSE:BGCBTG
05/12/201605:00PR Newswire (US)PneumRx® Coils Included in New Global Clinical Guidelines and Given Positive Recommendation to Treat Severe Emphysema Patien...LSE:BGCBTG
19/10/201604:00PR Newswire (US)First Patient in Malaysia Receives TheraSphere™ radioembolisation TherapyLSE:BGCBTG
14/10/201603:00PR Newswire (US)BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y™ Dosimetry Software in EuropeLSE:BGCBTG
09/09/201603:00PR Newswire (US)BTG Launches βETA™ Radiation Safety Programme, to Reduce the Risk of Radiation Exposure for Healthcare Professionals and P...LSE:BGCBTG
17/08/201608:00PR Newswire (US)CMS Grants Vistogard® New Technology Add-on Payment Status Effective 1 October 2016LSE:BGCBTG
02/08/201603:00PR Newswire (US)BTG Announces Successful CE Mark Reclassification for DC Bead® to Class III Based on its Ability to Administer MedicinesLSE:BGCBTG
26/05/201610:46PR Newswire (US)New Study Highlights Potential Cost Savings When Using Yttrium-90 Glass Microspheres for Treatment of Hepatocellular Carcinom...LSE:BGCBTG
02/04/201604:00PR Newswire (US)BTG to Initiate Multi-Centre TARGET Study Evaluating Dosimetry for 90Y Radioembolisation Therapy in Patients With Hepatocellu...LSE:BGCBTG
01/04/201608:00PR Newswire (US)BTG Announces US Launch of LC Bead LUMI™, Ground-Breaking Radiopaque Embolic BeadLSE:BGCBTG
26/01/201620:00PR Newswire (US)First Patients in South Korea Receive TheraSphere® Radioembolisation TreatmentLSE:BGCBTG
18/11/201509:15UK RegulatoryBTG PLC Director/PDMR ShareholdingLSE:BGCBTG
 Apresentando as notícias mais relevantes sobre:LSE:BGC

Seu Histórico Recente

COIN
BZZZETH
Bzz
UNSW3
NBNGUSDT
NOBUNAGA
BIT
UC2XV2
Unicredit Bank
BITMOT
970204
Poland Tf 3,875% Fb33 Eur
COIN
FTXTBTC
FUTURAX
BFNX
MKRUST
COIN
POLKGBP
Polkamarkets
BIT
1PG
Procter and Gamble
UNSW
LBDETH
Linkbased
COIN
SAFUST
SafCoin
LSE
AR24
Places Tr 55
NASDAQ
HSXAX
Hartford Schroders Diver...
KUCN
SUBBTC
Substratum
BIT
S31924
Societe Generale Effekten
BIT
GS0252
Goldman Sachs
LSE
BAR
Brand Architekts
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados